科创信息(300730) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 96,875,986.33, down 10.11% year-on-year[7] - Net profit attributable to shareholders was CNY 5,228,735.96, a significant decline of 47.88% compared to the same period last year[7] - Basic earnings per share were CNY 0.0332, down 47.72% year-on-year[7] - Operating profit for the current period is ¥5,086,659.89, down from ¥9,265,917.66, indicating a decline of approximately 45.0%[41] - Net profit for the current period is ¥5,181,292.40, compared to ¥10,241,363.29 in the previous period, reflecting a decrease of about 49.3%[41] - The company's operating revenue for the current period reached CNY 208.63 million, an increase from CNY 181.50 million in the previous period, representing a growth of approximately 14.93%[50] - The net profit for the current period was a loss of CNY 9.27 million, compared to a profit of CNY 511,061.07 in the previous period, indicating a significant decline[49] - The total profit for the current period was a loss of CNY 9.06 million, contrasting with a profit of CNY 412,879.10 in the previous period[48] Assets and Liabilities - Total assets at the end of the reporting period were CNY 639,938,799.49, a decrease of 1.65% compared to the end of the previous year[7] - Total liabilities rose to CNY 218,503,465.81 from CNY 210,026,256.29, marking an increase of about 1.41%[33] - The company's equity decreased to CNY 421,435,333.68 from CNY 440,676,373.04, a decline of approximately 4.36%[34] - Cash and cash equivalents decreased by 58.03% to ¥75,881,075.03 due to payments for procurement[19] - Current assets totaled CNY 498,034,617.21, slightly down from CNY 501,489,406.76, indicating a decrease of about 0.91%[31] - The company reported a total current liability of CNY 193,641,113.02, up from CNY 183,737,920.04, indicating an increase of about 5.0%[33] - The total non-current liabilities include deferred income of CNY 16,500,000.00, which represents income received but not yet recognized[64] Cash Flow - The net cash flow from operating activities was CNY 5,214,599.60, an increase of 120.13% compared to the previous year[7] - The cash flow from operating activities showed a decrease in outflows, with total cash outflows of 283,969,612.62 CNY, down from 296,735,049.05 CNY[57] - The cash inflow from investment activities totaled 4,715,033.50 CNY, while cash outflows were 1,647,351.51 CNY, leading to a net cash inflow of 3,067,681.99 CNY[56] - The cash flow from operating activities resulted in a net outflow of CNY 85.44 million, an improvement from a net outflow of CNY 115.30 million in the previous period[55] Shareholder Information - The company reported a total of 22,567 common shareholders at the end of the reporting period[11] - The top three shareholders held a combined 24.06% of the shares, with Fei Yaoping holding 8.73%[11] - The company did not engage in any repurchase transactions during the reporting period[12] Research and Development - Research and development expenses increased to ¥10,060,233.80 from ¥5,601,482.77, marking an increase of approximately 79.5%[40] - The company reported a significant increase in R&D expenses, indicating a strategic focus on innovation and technology development[40] - Research and development expenses increased to CNY 22.74 million from CNY 19.33 million, reflecting a growth of approximately 17.00%[50] Other Financial Metrics - The weighted average return on net assets was 1.05%, a decrease of 1.25% compared to the previous year[7] - Cash paid for various taxes decreased by 43.46% to ¥15,332,472.01 due to reduced tax payments[21] - The company received ¥9,778,800.00 from the issuance of restricted stock, marking a 100% increase in cash from investment[21] - The company executed a stock option and restricted stock incentive plan, granting 2.39 million stock options and 1.405 million restricted shares[22] - There were no violations regarding external guarantees or non-operating fund occupation by controlling shareholders during the reporting period[24]